Literature DB >> 20512942

Sentinel node biopsy in melanoma: technical considerations of the procedure as performed at the John Wayne Cancer Institute.

Sanjay P Bagaria1, Mark B Faries, Donald L Morton.   

Abstract

Since its first description in 1990, sentinel node (SN) biopsy has become the standard for accurate staging of a melanoma-draining regional lymphatic basin. This minimally invasive, multidisciplinary technique can detect occult metastases by selective sampling and focused pathologic analysis of the first nodes on the afferent lymphatic pathway from a primary cutaneous melanoma. An understanding of preoperative lymphoscintigraphy, intraoperative lymphatic mapping, and the definition of SN are critical for surgical expertise with SN biopsy. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20512942      PMCID: PMC2879706          DOI: 10.1002/jso.21581

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  61 in total

1.  Will the true sentinel node please stand?

Authors:  D L Morton; P J Bostick
Journal:  Ann Surg Oncol       Date:  1999 Jan-Feb       Impact factor: 5.344

2.  Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group.

Authors:  D L Morton; J F Thompson; R Essner; R Elashoff; S L Stern; O E Nieweg; D F Roses; C P Karakousis; N Mozzillo; D Reintgen; H J Wang; E C Glass; A J Cochran
Journal:  Ann Surg       Date:  1999-10       Impact factor: 12.969

Review 3.  The role of lymphoscintigraphy and sentinel node mapping in assessing patient risk in melanoma.

Authors:  R Essner
Journal:  Semin Oncol       Date:  1997-02       Impact factor: 4.929

4.  Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger.

Authors:  C M Balch; S J Soong; A A Bartolucci; M M Urist; C P Karakousis; T J Smith; W J Temple; M I Ross; W R Jewell; M C Mihm; R L Barnhill; H J Wanebo
Journal:  Ann Surg       Date:  1996-09       Impact factor: 12.969

5.  Lymphatic drainage of skin to a sentinel lymph node in a feline model.

Authors:  J H Wong; L A Cagle; D L Morton
Journal:  Ann Surg       Date:  1991-11       Impact factor: 12.969

6.  Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic.

Authors:  D L Morton; L Wanek; J A Nizze; R M Elashoff; J H Wong
Journal:  Ann Surg       Date:  1991-10       Impact factor: 12.969

7.  Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck.

Authors:  D L Morton; D R Wen; L J Foshag; R Essner; A Cochran
Journal:  J Clin Oncol       Date:  1993-09       Impact factor: 44.544

8.  Demonstration of second-tier lymph nodes during preoperative lymphoscintigraphy for melanoma: incidence varies with primary tumor site.

Authors:  R F Uren; R B Howman-Giles; J F Thompson
Journal:  Ann Surg Oncol       Date:  1998-09       Impact factor: 5.344

9.  Kinetics of three lymphoscintigraphic agents in patients with cutaneous melanoma.

Authors:  E C Glass; R Essner; D L Morton
Journal:  J Nucl Med       Date:  1998-07       Impact factor: 10.057

10.  Variability of cutaneous lymphatic flow rates in melanoma patients.

Authors:  R F Uren; R B Howman-Giles; J F Thompson; J Roberts; E Bernard
Journal:  Melanoma Res       Date:  1998-06       Impact factor: 3.599

View more
  17 in total

Review 1.  Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles.

Authors:  Shuang Cai; Qiuhong Yang; Taryn R Bagby; M Laird Forrest
Journal:  Adv Drug Deliv Rev       Date:  2011-06-25       Impact factor: 15.470

2.  Impact of Time Between Diagnosis and SLNB on Outcomes in Cutaneous Melanoma.

Authors:  Daniel W Nelson; Stacey Stern; David E Elashoff; Robert Elashoff; John F Thompson; Nicola Mozzillo; Omgo E Nieweg; Harald J Hoekstra; Alistair J Cochran; Mark B Faries
Journal:  J Am Coll Surg       Date:  2017-06-28       Impact factor: 6.113

Review 3.  Melanoma and nuclear medicine.

Authors:  Andrés Perissinotti; Sergi Vidal-Sicart; Omgo Nieweg; Renato Valdés Olmos
Journal:  Melanoma Manag       Date:  2014-09-05

4.  Radioguided exploration facilitates surgical cytoreduction of neuroendocrine tumors.

Authors:  Yi-Zarn Wang; Anne Diebold; Eugene Woltering; Heather King; J Philip Boudreaux; Lowell B Anthony; Richard Campeau
Journal:  J Gastrointest Surg       Date:  2011-11-22       Impact factor: 3.452

5.  Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.

Authors:  David Y Lee; Briana J Lau; Kelly T Huynh; Devin C Flaherty; Ji-Hey Lee; Stacey L Stern; Steve J O'Day; Leland J Foshag; Mark B Faries
Journal:  J Am Coll Surg       Date:  2016-01-29       Impact factor: 6.113

6.  Red meat and fruit intake is prognostic among patients with localized cutaneous melanomas more than 1mm thick.

Authors:  Bonnie E Gould Rothberg; Kaleigh J Bulloch; Judith A Fine; Raymond L Barnhill; Marianne Berwick
Journal:  Cancer Epidemiol       Date:  2014-09-05       Impact factor: 2.984

7.  Predictors and Survival Impact of False-Negative Sentinel Nodes in Melanoma.

Authors:  David Y Lee; Kelly T Huynh; Annabelle Teng; Briana J Lau; Sarah Vitug; Ji-Hey Lee; Stacey L Stern; Leland J Foshag; Mark B Faries
Journal:  Ann Surg Oncol       Date:  2015-11-19       Impact factor: 5.344

8.  Interval sentinel lymph nodes: an unusual localization in patients with cutaneous melanoma.

Authors:  A M Manganoni; R Farfaglia; E Sereni; C Farisoglio; C Pizzocaro; D Marocolo; F Gavazzoni; L Pavoni; P Calzavara-Pinton
Journal:  Dermatol Res Pract       Date:  2011-05-04

9.  Nuclear beta-catenin overexpression in metastatic sentinel lymph node is associated with synchronous liver metastasis in colorectal cancer.

Authors:  Hongxia Cheng; Hui Liang; Yejun Qin; Ying Liu
Journal:  Diagn Pathol       Date:  2011-11-04       Impact factor: 2.644

10.  Malignant melanoma.

Authors:  Aída Ortega Candil; Cristina Rodríguez Rey; José Luis Carreras Delgado
Journal:  ISRN Dermatol       Date:  2012-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.